Variant report
Variant | esv275012 |
---|---|
Chromosome Location | chr2:57681537-57690006 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs560911473 | chr2:57681577-57681578 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs7571066 | chr2:57681594-57681595 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs552631148 | chr2:57681595-57681596 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs571635368 | chr2:57681601-57681602 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs566344284 | chr2:57681607-57681608 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs7571099 | chr2:57681645-57681646 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
7 | rs138308992 | chr2:57681658-57681659 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs76361849 | chr2:57681668-57681669 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs143891378 | chr2:57681679-57681680 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs538549479 | chr2:57681681-57681682 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs537190598 | chr2:57681703-57681704 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs7571200 | chr2:57681715-57681716 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs577198350 | chr2:57681736-57681737 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs539785391 | chr2:57681750-57681751 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs78457155 | chr2:57681767-57681768 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs186945203 | chr2:57681788-57681789 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs369935334 | chr2:57681795-57681796 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs561584843 | chr2:57681808-57681809 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs72814597 | chr2:57681814-57681815 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs2222228 | chr2:57681816-57681817 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs147272688 | chr2:57681848-57681849 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs368989770 | chr2:57681858-57681859 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs373240778 | chr2:57681892-57681893 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs532807716 | chr2:57681905-57681906 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs72814599 | chr2:57681910-57681911 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs140863227 | chr2:57681947-57681948 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs149928548 | chr2:57681956-57681957 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs377694215 | chr2:57681958-57681959 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs144073193 | chr2:57682010-57682011 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs183327067 | chr2:57682044-57682045 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs980861 | chr2:57682057-57682058 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
32 | rs79982931 | chr2:57682079-57682080 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs117361312 | chr2:57682088-57682089 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs76101910 | chr2:57682099-57682100 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs201699671 | chr2:57682105-57682106 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs552908673 | chr2:57682117-57682118 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs76113262 | chr2:57682121-57682122 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs557445223 | chr2:57682123-57682124 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs535403502 | chr2:57682133-57682134 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs200571721 | chr2:57682177-57682178 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs555218725 | chr2:57682198-57682199 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs980860 | chr2:57682213-57682214 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs71393576 | chr2:57682249-57682250 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs980859 | chr2:57682251-57682252 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs35563101 | chr2:57682257-57682258 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs75533305 | chr2:57682259-57682260 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs564050434 | chr2:57682366-57682367 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs577623113 | chr2:57682379-57682380 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs187768210 | chr2:57682397-57682398 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs563381374 | chr2:57687207-57687208 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 16272173 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
Mental retardation | 19951919 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Microcephaly | 20799320 | CNVD |
camptodactyly | 20799320 | CNVD |
cognitive delay | 20799320 | CNVD |
prenatal and postnatal growth deficiency | 20799320 | CNVD |
ptosis of eyelids | 20799320 | CNVD |
Maculopathy | 20981449 | CNVD |
2p16.1 microdeletion syndrome | 22283845 | CNVD |
Autism | 22579565 | CNVD |
Autism | 16963482 | CNVD |
Autism | 21750575 | CNVD |
idiopathic intellectual disability | 16963482 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:57677800-57681800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr2:57681400-57681600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
3 | chr2:57681800-57682400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr2:57687200-57692400 | Weak transcription | Right Atrium | heart |
5 | chr2:57688200-57689800 | Enhancers | Fetal Brain Male | brain |
6 | chr2:57688600-57688800 | Enhancers | Fetal Brain Female | brain |
7 | chr2:57689400-57689600 | Enhancers | Fetal Brain Female | brain |